Results 1 to 10 of about 432,095 (196)

Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure [PDF]

Diagnostics
Background: Heart failure is a global major healthcare problem with millions of hospitalizations annually and with a very high mortality. There is an increased interest in finding new and reliable biomarkers for the diagnostic, prognostic and therapeutic
Mihai Cristian Marinescu, Violeta Diana Oprea, Sorina Nicoleta Munteanu, Aurel Nechita, Dana Tutunaru, Luiza Camelia Nechita, Aurelia Romila   +6 more
doaj   +2 more sources

Recurrent patterns and prognostic factors based on CA-125 and RECIST progression in ovarian cancer patients treated with poly (ADP-ribose) polymerase inhibitors [PDF]

Journal of Ovarian Research
Background Response Evaluation Criteria in Solid Tumors (RECIST) and CA-125 criteria are widely used to evaluate disease progression (PD) in ovarian cancer patients undergoing chemotherapy.
Bingxin Zhang, Weiwei Lv, Zhaojing Fu, Yu Zhou, Jiale Du, Qinxi Yao, Qiuhong Qian, Hualei Bu   +7 more
doaj   +2 more sources

Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125 [PDF]

Frontiers in Molecular Biosciences
BackgroundTumor markers are established laboratory tools that help to diagnose, estimate prognosis, and monitor the course of cancer. For meaningful decision-making in patient care, it is essential that methods and analytical platforms demonstrate high ...
Marcel Kremser, Nathalie Weiss, Anne Kaufmann-Stoeck, Laura Vierbaum, Arthur Schmitz, Ingo Schellenberg, Ingo Schellenberg, Stefan Holdenrieder, Stefan Holdenrieder   +8 more
doaj   +2 more sources

CA 125: History, Current Status, and Future Prospects

McGill Journal of Medicine, 2020
N ...
Robert C., Jr Bast, Robert C. Knapp
doaj   +1 more source

CA 125 Elevation: A Descriptive Etiological Study [PDF]

National Journal of Laboratory Medicine, 2016
Introduction: CA 125 (Cancer/Carbohydrate antigen 125) is a surface antigen expressed mostly by the ovarian cancer cells. Hence, it is widely used as a tumour marker for detection and monitoring the progression of such cancers.
Shaheena Appan Parambath, Charu Yadav, Madan Gopal Ranjan, Anupama Hegde, Ashok Prabhu, Poornima Ajay Manjrekar, Rukmini Mysore Srikantiah   +6 more
doaj   +1 more source

Karakteristik Karsinoma Ovarium Pra-Menopause dengan Kadar CA 125 ≤200 U/mL di RSUP Dr. Hasan Sadikin Bandung dari Tahun 2019–2021

Obgynia, 2023
Tujuan: Mendeskripsikan karakteristik karsinoma ovarium pra-menopause dengan kadar CA 125 ≤ 200 U/mL di RSUP Dr. Hasan Sadikin Bandung dari tahun 2019 sampai 2021.
Yudi Mulyana Hidayat, Eunike Febe Febriani, Ali Budi Harsono, Gatot N. A. Winarno, Andi Kurniadi   +4 more
doaj   +1 more source

Struma Ovarii with Elevated Ca-125 Levels and Ascites Mimicking Advanced Ca Ovary [PDF]

Journal of Clinical and Diagnostic Research, 2014
Struma ovarii is uncommon tumor of ovary which can mimic as advanced carcinoma of ovary. Thyroid tissue is relatively frequent constituent of mature ovarian teratoma.
Navin Kumar Sinha
doaj   +1 more source

Evaluating Lung Cancer with Tumor Markers: CEA, CA 19-9 and CA 125

Journal of Contemporary Medicine, 2021
Aim: Lung cancer (LC) is a common and mortal malignancy. Tumor biomarkers are measurable biochemicals associated with cancer cells. Tumor markers cannot diagnose cancer; instead, they can be used as laboratory tests to support the diagnosis.
Aydın Balcı, Suphi Aydın, Muhammed Emin   +2 more
doaj   +1 more source

Correlation of CA-125 with different stages of endometriosis

Bangabandhu Sheikh Mujib Medical University Journal, 2018
This study was conducted to evaluate the association of serum cancer antigen (CA-125) level with the severity of pelvic endometriosis. Seventy diagnosed cases of pelvic endometriosis were included in this study.
Runa Laila, Begum Nasrin, Shayela Shamim, Md. Mozammel Hoque   +3 more
doaj   +1 more source

Immunohistochemistry of CA 125

The International Journal of Biological Markers, 1998
CA 125 is known as the marker that is most strongly associated with epithelial gynecological tumors. Compared to the number of publications on its use in serum assays, the application in immunohistochemistry is still limited.
M. Nap
doaj   +1 more source